Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2000 participants
OBSERVATIONAL
2014-12-31
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
transcatheter aortic valve Replacement
Patients with symptomatic severe aortic stenosis who are not candidates for surgical aortic valve replacement because of coexisting illnesses.
Transcatheter aortic valve Replacement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcatheter aortic valve Replacement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asan Medical Center
OTHER
Cardiovascular Clinical Research
INDUSTRY
Michael Kang-Yin Lee, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Kang-Yin Lee, MD
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Seung-jung Park, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Asan Medical Center, Republic of Korea
Edgar L.W. Tay, MD
Role: PRINCIPAL_INVESTIGATOR
National University Heart Center (National University Health System), Singapore
Machael Kang-Yin Lee, MD
Role: PRINCIPAL_INVESTIGATOR
Queen Elizabeth Hospital, HongKong
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Queen Elizabeth Hospital
Hong Kong, , China
Nanjing 1st Hospital
Nanjing, , China
Shonan Kamakura General Hospital
Kamakura, , Japan
Institut Jantung Negara
Kuala Lumpur, , Malaysia
St. Luke's Medical Center
Bonifacio, , Philippines
National Heart Centre of Singapore
Singapore, , Singapore
National University Heart Centre
Singapore, , Singapore
Asan Medical Center
Seoul, , South Korea
National Taiwan University
Taipei, , Taiwan
King Chulalongkorn Memorial Hospital
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AMCCV 2013-12
Identifier Type: -
Identifier Source: org_study_id